hearing loss
UK Provides £1.4M in Funding for Two-Year Study on Genedrive Test to Prevent Newborn Hearing Loss
The Manchester University NHS Foundation Trust will study across the UK the use of Genedrive's MT-RNR1 ID Kit as a pharmacogenomic test to prevent hearing loss.
Childhood Hearing Loss Symptoms, Severity Informed by Adult Polygenic Risk Score
Using data from two Australian cohorts, researchers found that a PRS for hearing loss in adults could offer clues to childhood hearing loss risk and severity.
NICE Recommends Genedrive Test in Draft Guidance to Prevent Hearing Loss in Newborns
NICE recommended that Genedrive's MT-RNR1 ID Kit should be adopted by the NHS for the prevention of antibiotic-induced hearing loss.
Cochlear Implant Outcomes Linked to Type of Genetic Diagnosis for Childhood Hearing Loss
Data from more than 400 families affected by childhood-onset hearing loss indicated that specific genes and variants can provide prognostic clues, including success of cochlear implants.
UK's NICE to Accelerate Assessment of Genedrive Test
NICE plans to assess Genedrive's MT-RNR1 test for antibiotics-induced hearing loss in infants via a new program.